PoliticsTimes of India
0%, 100%, then 200%: How Trump's new generic drug tariff plan could hit India
in5points
Donald Trump announced phased tariffs on imported generic medicines starting August 2026.
Tariffs will increase to 200 percent over three years, aiming to reshore pharmaceutical production to the US.
India, as a major supplier of affordable generics, faces significant impact from these changes.
The move adds uncertainty to ongoing bilateral trade agreement between US and India.
Story angle
Center-right
L
CL
C
CR
R
Mostly straight facts, with a light government- or market-friendly tilt.
About how the story is framed, not whether the facts are true.
Times of India
Center-right
Mixed factuality
Who owns this?
Times Group
Bennett, Coleman & Co. (Sahu Jain family)
India's largest newspaper group by circulation.
Wikipedia: Sahu Jain family